Intrommune Therapeutics

Intrommune is developing prescription and consumer solutions to counter the global health burden of food allergies and their life-threatening consequences.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location New York, NY, USA
  • Currency USD
  • Founded December 2013
  • Employees 3
  • Incorporation Type C-corp
  • Website intrommune.com

Company Summary

Intrommune is developing safe, effective, and easy-to-use solutions to counter the global health burden of food allergies and their life-threatening consequences. Its core OMIT Platform technology enables self-administration of treatment via a specially formulated toothpaste that incorporates and stabilizes proteins. Immunomodulatory agents are delivered throughout the oral cavity to efficiently and safely drive the immune system toward tolerance

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free